Clinical Trial Update: OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating outpatient intravenous furosemide (Lasix) to reduce hospitalization for acute decompensated heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: New York Presbyterian Brooklyn Methodist Hospital | Conditions: Heart Failure | Phase 4 | Status: COMPLETED